Comprising the majority of “primary” or “de novo” glioblastoma (those occurring without a documented precursor lesion), IDH-wildtype GBMs (Table 5) characteristically have the worst clinical outcome and prognosis of all diffuse infiltrating gliomas in adults [4]. The gene discussed is IDH2; the disease is glioblastoma.